Italian contrast firm Bracco Imaging of Milan is planning a direct entry into the Korean market.
A report in the JoongAng Daily states that Bracco Korea aims to provide medical contrast agents to Korean healthcare providers and compete with Bayer Schering Pharma of Berlin and GE Healthcare of Chalfont St. Giles, U.K.
According to the publication, Ilsung Pharmaceutical had an exclusive right to sell Bracco products in Korea, but Bracco Korea has recovered that right from Ilsung.
Related Reading
GE, Bracco receive FDA violation notices, January 25, 2010
Judge gives Bracco partial victory in patent case, August 28, 2009
Bracco debuts new CardioGen pump at SNM show, June 15, 2009
Mallinckrodt sues Bracco, April 9, 2009
Court orders GE to pay Bracco, correct Visipaque ads, March 30, 2009
Copyright © 2010 AuntMinnie.com
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
